Bluebook
Pharma Services Blue Book November 2024
2024 - October: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Trial Management Associates was acquired by Headlands Research
- TA Associates announced its acquisition of Nexus AG
- AmplifyBio closed a $50MM Series A Financing, led by Vitrian